🔎 Trials Near Me

Utama › Melanoma Uveal › Colorado

Kajian klinikal Melanoma Uveal di Colorado

7 kajian untuk Melanoma Uveal sedang mencari peserta di lokasi di Colorado.

Bandar di Colorado

Teks kajian rasmi (Bahasa Inggeris)

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

  • University of Colorado Cancer Center, Aurora
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06070012

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

  • SCRI Oncology Partners- Denver, Denver
Mengambil pesertaFasa 1/2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 15 Jun 2026 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

  • SCRI - Denver, Denver
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT03947385

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • University of Colorado, Anschutz Medical Campus, Aurora
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mei 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • University of Colorado Hospital, Aurora
  • The Melanoma and Skin Cancer Institute, Englewood
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora
  • The Melanoma & Skin Cancer Institute, Englewood
Mengambil pesertaFasa 2/3
Semua umur · Semua jantina · Dikemas kini 2 Apr 2026 · NCT06581406

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

  • Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Nov 2025 · NCT07136181

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.